Copayment and Premium Assistance Available for Individuals with Huntington’s Disease
New York, NY (May 2, 2017) —The Huntington’s Disease Society of America (HDSA) is proud to announce a valuable partnership with the The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a Movement Disorders Fund to provide copayment and premium assistance to eligible Medicare patients. Through the fund, HealthWell will provide up to $10,000 in copayment or premium assistance to individuals who have annual household incomes up to 500 percent of the federal poverty level. The new fund will assist patients in several different movement-related disease areas, including, but not limited to, Huntington’s disease, Tourette syndrome, Parkinson ’s disease, Chorea, Tardive Dyskinesia and General Dyskinesia.
“The assistance that the HealthWell Foundation will be able to provide to individuals living with Huntington’s disease through this fund addresses an unmet and critical need,” said Louise Vetter, President and Chief Executive Officer, Huntington’s Disease Society of America. “Huntington’s disease (HD) is a devastating and debilitating disease for which there is no cure. Offering copayment and premium assistance as a resource to HD patients and their families will certainly go a long way in diminishing some of the financial obstacles they face in treating their disease.”
To learn more about the fund and to determine eligibility and apply for financial assistance, visit HealthWell’s Movement Disorders Fund page at www.HealthWellFoundation.org.
Huntington’s disease is a fatal genetic disorder that causes the progressive breakdown of nerve cells in the brain. It deteriorates a person’s physical and mental abilities during their prime working years and has no cure. Every child of a parent with HD has a 50/50 chance of inheriting the faulty gene that causes HD. Today, there are approximately 30,000 symptomatic Americans and more than 200,000 at-risk of inheriting the disease.
The symptoms of HD are described as having, ALS, Parkinson’s and Alzheimer’s – simultaneously.
About the Huntington’s Disease Society of America
The Huntington’s Disease Society of America is the premier nonprofit organization dedicated to improving the lives of everyone affected by HD. From community services and education to advocacy and research, HDSA is the world’s leader in providing help for today, hope for tomorrow for people with HD and their families.
To learn more about Huntington’s disease and the work of the Huntington’s Disease Society of America, visit www.hdsa.org or call (800) 345-HDSA.
Contact: Christopher Cosentino
Director of Marketing & Communications
Phone: (212) 242-1968 x229
Email: ccosentino@hdsa.org
